he Multi-Drug Rapid Test Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations
TRA
THC
BENZO
BARA
COC
AMP
MOP .
The Multi-Drug Rapid Test Panel is a rapid urine screening test that can be
performed without the use of an instrument. The test utilizes monoclonal
antibodies to selectively detect elevated levels of specific drugs in urine.
Amphetamine (AMP 1,000)
Amphetamine is a Schedule II controlled substance available by prescription
(Dexedrine®) and is also available on the illicit market. Amphetamines are a
class of potent sympathomimetic agents with therapeutic applications.They are
chemically related to the human body’s natural catecholamines: epinephrine and
norepinephrine. Acute higher doses lead to enhanced stimulation of the central
nervous system (CNS) and induce euphoria, alertness, reduced appetite, an a
sense of increased energy and power. Cardiovascular responses to
amphetamines include increased blood pressure and cardiac arrhythmias. More
acute responses produce anxiety, paranoia, hallucinations, and psychotic
behavior. The effects of Amphetamines generally last 2-4 hours following use
and the drug has a half-life of 4-24 hours in the body. About 30% of
amphetamines are excreted in the urine in unchanged form, with the remainder
as hydroxylated and deaminated derivatives.
The Multi-Drug Rapid Test Panel yields a positive result when the concentration
of amphetamines in urine exceeds 1,000 ng/mL. This is the suggested screening
cut-off for positive specimens set by the Substance Abuse and Mental Health
Services Administration (SAMHSA, USA).1 .
Materials Provided
